News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tauriga Sciences Inc. (TAUG) Actively Evaluating Potential Acquisition Targets to Restore and Create Lasting Shareholder Value



9/3/2013 9:58:17 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LOS ANGELES, Sept. 3, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) ("Tauriga" or "the Company"), a diversified company focused on generating profitable revenues through license agreements and evaluating potentially lucrative acquisition targets in an industry agnostic manner, has today announced that the Company's management and Board of Directors ("BOD") are actively evaluating potential acquisition candidates to both restore and create lasting shareholder value. The Company has established rigorous due diligence protocols pursuant to the evaluation process and believes that a number of intriguing opportunities currently exist in the technology marketplace. The Company has also made the decision to become industry agnostic. That is Tauriga will be open and available to potential acquisition targets regardless of industry or sector. In addition the Company shall require that a minimum of 4 out of its 5 directors ("effective majority") must vote in favor of entering into any future definitive agreement with potential acquisition candidates.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES